Non-pharmacologic treatments may be more effective for psychiatric symptoms of dementia

by St. Michael's HospitalCredit: CC0 Public DomainFor patients with dementia who have symptoms of aggression and agitation, interventions such as outdoor activities, massage and touch therapy

Updated on: June 01,2024

Non-pharmacologic treatments may be more effective for psychiatric symptoms of dementia

by St. Michael's HospitalCredit: CC0 Public DomainFor patients with dementia who have symptoms of aggression and agitation, interventions such as outdoor activities, massage and touch therapy

Updated on:June 01,2024

Traumatic brain injury may raise veterans' long-term stroke risk

by Michael Merschel, American Heart Association NewsMilitary veterans who had a traumatic brain injury may have an increased long-term risk of stroke, new research suggests.The study, which used data

Updated on: February 03,2024

Traumatic brain injury may raise veterans' long-term stroke risk

by Michael Merschel, American Heart Association NewsMilitary veterans who had a traumatic brain injury may have an increased long-term risk of stroke, new research suggests.The study, which used data

Updated on:February 03,2024

New insights into the formation of toxic protein clumps in Alzheimer's disease

byForschungszentrum JuelichSmall Aβ oligomers (left: cryo-electron microscopy) are clumps consisting of just a few Aβ molecules. They cluster together to form short, worm-like structures known a

Updated on: April 18,2024

New insights into the formation of toxic protein clumps in Alzheimer's disease

byForschungszentrum JuelichSmall Aβ oligomers (left: cryo-electron microscopy) are clumps consisting of just a few Aβ molecules. They cluster together to form short, worm-like structures known a

Updated on:April 18,2024

Aduhelm: Will Medicare cover the controversial Alzheimer's drug?

by Dennis Thompson(HealthDay)—Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial A

Updated on: March 26,2024

Aduhelm: Will Medicare cover the controversial Alzheimer's drug?

by Dennis Thompson(HealthDay)—Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial A

Updated on:March 26,2024

Anticoagulants fail to prevent unexplained strokes, clinical trial finds

by Columbia University Irving Medical CenterVisual Abstract.Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy. Credit:JAMA, (2024). doi:10.10

Updated on: May 21,2024

Anticoagulants fail to prevent unexplained strokes, clinical trial finds

by Columbia University Irving Medical CenterVisual Abstract.Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy. Credit:JAMA, (2024). doi:10.10

Updated on:May 21,2024

Molecular alterations in neuronal trophic regulation in Alzheimer's pathology

by Jason Clement,McGill UniversityCredit: Unsplash/CC0 Public DomainFor decades researchers have known that Alzheimer's disease (AD) causes the atrophy of a system of neurons and synapses hi

Updated on: April 02,2024

Molecular alterations in neuronal trophic regulation in Alzheimer's pathology

by Jason Clement,McGill UniversityCredit: Unsplash/CC0 Public DomainFor decades researchers have known that Alzheimer's disease (AD) causes the atrophy of a system of neurons and synapses hi

Updated on:April 02,2024

Dementia found to be the dominant risk factor for COVID in elderly care

by University of GothenburgHazard ratios (HR) and 95% Confidence intervals (CI) of the relationship between individual-level factors (age, sex, education, dementia, cardiovascular disease, lung d

Updated on: May 06,2024

Dementia found to be the dominant risk factor for COVID in elderly care

by University of GothenburgHazard ratios (HR) and 95% Confidence intervals (CI) of the relationship between individual-level factors (age, sex, education, dementia, cardiovascular disease, lung d

Updated on:May 06,2024

Facebook app offers opportunity to help unpaid Alzheimer's caregivers via friendsourcing

by Indiana UniversityDavid Wilkerson, an assistant professor in the IU School of Social Work and a member of the Facebook app research team. Credit: IU School of Social WorkResearchers at IUPUI h

Updated on: March 30,2024

Facebook app offers opportunity to help unpaid Alzheimer's caregivers via friendsourcing

by Indiana UniversityDavid Wilkerson, an assistant professor in the IU School of Social Work and a member of the Facebook app research team. Credit: IU School of Social WorkResearchers at IUPUI h

Updated on:March 30,2024

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

by Frederic Calon and Étienne Aumont,The ConversationCredit: AI-generated imageOn Nov. 30, Eisai and Biogen announced theresults of their latest phase 3 clinical trial in Alzheimer's d

Updated on: March 30,2024

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

by Frederic Calon and Étienne Aumont,The ConversationCredit: AI-generated imageOn Nov. 30, Eisai and Biogen announced theresults of their latest phase 3 clinical trial in Alzheimer's d

Updated on:March 30,2024

30 years on, are we winning the fight against Alzheimer's?

by Suzanne Leigh, University of CaliforniaA set of 16 brain PET scans, with orange areas representing Alzheimer's progression. Credit: UC San FranciscoUC San Francisco experts say that we have rea

Updated on: March 13,2024

30 years on, are we winning the fight against Alzheimer's?

by Suzanne Leigh, University of CaliforniaA set of 16 brain PET scans, with orange areas representing Alzheimer's progression. Credit: UC San FranciscoUC San Francisco experts say that we have rea

Updated on:March 13,2024

Study finds high prevalence of hidden brain changes in people with heart disease

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainA new analysis involving over 13,000 people has found changes to blood vessels in the brain that can increase the risk of str

Updated on: March 28,2024

Study finds high prevalence of hidden brain changes in people with heart disease

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainA new analysis involving over 13,000 people has found changes to blood vessels in the brain that can increase the risk of str

Updated on:March 28,2024

A new breakthrough in Alzheimer's disease research: Visualizing reactive astrocyte-neuron interaction

by Institute for Basic ScienceFig. 1. Augmentation of acetate uptake, mediated by MCT1, facilitates Aβ-induced GABA release in reactive astrocyte. A. Blockade effect of MCT1 inhibitor on 14C-acet

Updated on: April 16,2024

A new breakthrough in Alzheimer's disease research: Visualizing reactive astrocyte-neuron interaction

by Institute for Basic ScienceFig. 1. Augmentation of acetate uptake, mediated by MCT1, facilitates Aβ-induced GABA release in reactive astrocyte. A. Blockade effect of MCT1 inhibitor on 14C-acet

Updated on:April 16,2024